Erik Torenberg

Andy Jassy × Ben Horowitz × Erik Torenberg

Amazon expects about $220 billion of 2026 CapEx, yet AWS capacity is sold out for 2026, largely for 2027, and partly for 2028; AWS AI has exceeded a $25 billion revenue run rate.Data centers require investment roughly two years before monetization, pressuring free cash flow; broader enterprise inference adoption also hinges on costs Jassy still calls an order of magnitude too high.

Marc Andreessen × Ben Horowitz × Chris Dixon × Erik Torenberg

a16z is expanding the ACC Crypto Fund into a16z Frontier for “outer planets” beyond existing verticals as crypto’s boundaries blur with fintech and Wall Street.Marc Andreessen calls AI’s early-adopter gap with incumbents the widest of his career; employees adopting ahead of companies could fuel startup formation, while AI answers and Stack Overflow’s traffic drop point to an internet-economics reset.

Ben Horowitz × Martin Casado × Raghu Raghuram × Erik Torenberg

a16z’s new AI infrastructure fund captures a founder migration into hardware, with top-founder hardware pitches rising from roughly 3–5% to “north of 20% or 30%.”Hyperscaler capex, booked-out GPUs and resale premiums support opportunities across chips, power and cooling, while grid shortages, regulation and uncontrolled agent spending remain constraints.

Travis Kalanick × Ben Horowitz × Erik Torenberg

Atoms is applying full-stack industrial AI to food, mining, and transport, with production, logistics, robotics, and infrastructure unified as an “atoms-based computer.”Its 50% production-cost reduction, 50¢–$1 robotic delivery, and mining productivity now above humans support a path to lower-cost meals and faster deployment, while execution depends on management capacity and overcoming industrial regulation.

Erik Torenberg × Jake Paul × Geoff Woo

Anti Fund is pairing growth capital with Jake Paul’s scarce distribution advantage, backing names including Anduril, SpaceX, OpenAI and Anthropic as Woo argues that attention, not capital, is increasingly constrained.Paul’s experiment-measure-concentrate playbook and resilience underpin the partnership, while creator monetization, political and education ambitions, platform limits and the possibility of rapid AI imitation remain important variables.

Erik Torenberg × Nathan Labenz × Kyle Corbitt

RL can push capable open-weight models higher by reinforcing rare outcome-changing decisions while preserving pretrained “grooves,” unlike SFT’s broader risk of catastrophic forgetting.For enterprise agents, the clearest wedge is latency: RL can bring small models to roughly 30% of frontier latency and improve cost per token by at least an order of magnitude, though slower iteration and reward hacking remain risks.

Marc Andreessen × Erik Torenberg

Andreessen sees AI three years into an 80-year revolution, with customer revenue validating unusually rapid adoption across an already-built global distribution network.Falling token costs, competing chips, smaller models, and US-China rivalry could expand demand dramatically, while state regulation remains a major unresolved risk.

Erik Torenberg × Nathan Labenz × Zvi Moshowitz × Greg × Eugenia Kuyda × Ali Behrouz × Logan Kirkpatrick × Jungwon Hwang

AI’s strongest proof point is its performance alongside Nathan Labenz’s son’s oncologists, with minimal residual disease below one cell per million after remission before round two.Claude Opus 4.5 may be software AGI, but jagged failures and holiday hype leave full AGI unresolved, while context management, multi-model judgment, and infrastructure financing remain key risks.

Erik Torenberg × Patrick Hsu × Jorge Conde

Arc is combining neuroscience, immunology, machine learning, chemical biology, and genomics to reduce organizational and experimental latency, with virtual cells aimed at navigating diseased cells toward healthy states.The commercial prize depends on better targets, drug design, higher clinical success, lower capital intensity, and shorter timelines, but physical testing and human endpoints remain serial bottlenecks while virtual-cell capability sits somewhere between GPT-1 and GPT-2.

Erik Torenberg × Mark Cuban

Cuban’s clearest business thesis pairs transparent pricing and AI-native operators with broad employee equity, arguing that ESOP workers earn dramatically more and turn over less while small firms gain immediate productivity tools.He would replace opaque insurers and PBMs with patient shopping, catastrophic reinsurance, and government-guaranteed financing, while NBA media rights and second-apron constraints make subscription growth and patient team-building the next tests.